Galmed Pharmaceuticals Lt... (GLMD)
NASDAQ: GLMD
· Real-Time Price · USD
1.82
0.01 (0.55%)
At close: Jul 03, 2025, 3:40 PM
1.81
-0.80%
After-hours: Jul 03, 2025, 04:58 PM EDT
0.55% (1D)
| Bid | 1.78 |
| Market Cap | 4.12M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.35M |
| EPS (ttm) | -6.6 |
| PE Ratio (ttm) | -0.28 |
| Forward PE | -2.12 |
| Analyst | n/a |
| Ask | 1.87 |
| Volume | 110,435 |
| Avg. Volume (20D) | 1,754,490 |
| Open | 1.83 |
| Previous Close | 1.81 |
| Day's Range | 1.79 - 1.85 |
| 52-Week Range | 1.15 - 23.80 |
| Beta | 0.51 |
About GLMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLMD
Website n/a
2 months ago
+10.61%
Galmed Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
9 months ago
-11.93%
Galmed Pharmaceuticals shares are trading lower. The company announced that results of its Phase 3 trial of Aramchol in 150 patients with NASH and fibrosis has been published in Hepatology.
